Cytokine production through PKC/p38 signaling pathways, not through JAK/STAT1 pathway, in mast cells stimulated with IFNγ

Cytokine

Volumn 46, Issue 1, 2009, Pages 51-60

  Seo, Jung Youn ^a   Kim, Dae Yong ^a   Lee, Yun Song ^a   Ro, Jai Youl ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

IFN ; MAP kinases; Mast cells; PKC isoforms; Transcription factors

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE 1; JANUS KINASE 2; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE C; STAT1 PROTEIN;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL FRACTIONATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA BINDING; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; MAST CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CYTOKINES; ENZYME ACTIVATION; FEMALE; HUMANS; INFLAMMATION; INTERFERON-GAMMA; JANUS KINASE 1; MAST CELLS; MICE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN KINASE C; STAT1 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP-1;

EID: 62749135923     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.12.008     Document Type: Article

References (53)

1. Metcalfe D.D., Baram D., and Mekori Y.A. Mast cells. Physiol Rev 77 (1997) 1033-1079
2. Reischl I.G., Coward W.R., and Church M.K. Molecular consequences of human mast cell activation following immunoglobulin E-high affinity immunoglobulin E receptor (IgE-FcεRI) interaction. Biochem Pharmacol 58 (1999) 1841-1850
3. Gilfillan A.M., and Tkaczyk C. Integrated signaling pathways for mast cell activation. Nat Rev Immunol 6 (2006) 218-230
4. Blank U., and Rivera J. The ins and outs of IgE-dependent mast cell exocytosis. Trends Immunol 25 (2004) 266-273
5. Vennekens R., Olausson J., Meissner M., Bloch W., Mathar I., Philipp S.E., et al. Increased IgE-dependent mast cell activation and anaphylactic responses in mice lacking the calcium-activated non-selective cation channel TRPM4. Nat Immunol 8 (2007) 312-320
6. Couturier N., Zappulla J.P., Lauwers-Cances V., Uro-Coste E., Delisle M.B., Clanet M., et al. Mast cell transcripts are increased within and outside multiple sclerosis lesions. J Neuroimmunol 195 (2008) 176-185
7. Medic N., Vita F., Abbate R., Soranzo M.R., Pacor S., Fabbrett E., et al. Mast cell activation by myelin through scavenger receptor. J Neuroimmunol 200 (2008) 27-40
8. Nigrovic P., and Lee D.M. Mast cells in inflammatory arthritis. Arthritis Res Ther 7 (2005) 1-11
9. Palmer H.S., Kelso E.B., Lockhart J.C., Sommerhoff C.P., Plevin R., Goh F.G., et al. Protease-activated receptor 2 mediates the proinflammatory effects of synovial mast cells. Arthritis Rheum 56 (2007) 3532-3540
10. Wei O.L., Hilliard A., Kalman D., and Sherman M. Mast cells limit systemic bacterial dissemination but not colitis in response to Citrobacter rodentium. Infect Immun 73 (2005) 1978-1985
11. Rocha-dw-Souza C.M., Berent-Maoz B., Mankuta D., Moses A.E., and Levi-Schaffer F. Human mast cell activation by Staphylococcus aureus: IL-8 and TNF-α release and the role of Too-like receptor 2 and CD48 molecules. Infect Immun 76 (2008) 4489-4497
12. Shin K., Watts G.F., Oettgen H.C., Friend D.S., Pemberton A.D., Gurish M.F., et al. Mouse mast cell tryptase mMCP-6 is a critical link between adaptive and innate immunity in the chronic phase of Trichinella spiralis infection 180 (2008) 4885-4891
13. Kobayashi R., Okamura S., Ohno T., Saito H., Mori M., Ra C., et al. Hyperexpression of FcγRI and Toll-like receptor 4 in the intestinal mast cell of Crohn's disease patients. Clin Immunol 125 (2007) 149-158
14. Skurkovich B., and Skurkovich S. Anti-interferon-γ antibodies in the treatment of autoimmune diseases. Curr Opin Mol Ther 5 (2003) 52-57
15. Hume D.A., Ravasi T., Hertzog P.J., and Schroder K. Interferon-γ: an overview of signals, mechanisms and functions. J Leukoc Biol 75 (2004) 163-189
16. Stark G.R., Kerr I.M., Williams B.R.G., and Silverman R.H. Schreiber RD: how cells respond to interferons. Annu Rev Biochem 67 (1998) 227-264
17. Kulka M., and Metcalfe D.D. High-resolution tracking of cell division demonstrates differential effects of Th1 and Th2 cytokines on SCF-dependent human mast cell production in vitro: correlation with apoptosis and Kit expression. Blood 105 (2005) 592-599
18. Goh K.C., Haque S.J., and Williams B.R. P38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons. EMBO J 18 (1999) 5601-5608
19. Kovarik P., Stoiber D., Eyers P.A., Menghini R., Neininger A., Gaestel M., et al. Stress-induced phosphorylation of STAT1 at Ser727 requires p38 mitogen-activated protein kinase whereas IFN-γ uses a different signaling pathway. Proc Natl Acad Sci USA 96 (1999) 13956-13961
20. Kovarik P., Mongold M., Ramsauer K., Heidari H., Steinborn R., Zotter A., et al. Specificity of signaling by STAT1 depends on SH2 and C-terminal domains that regulate Ser727 phosphorylation, differentially affecting specific target gene expression. EMBO J 20 (2001) 91-100
21. Yao Y., Xu Q., Kwon M.-J., Matta R., Liu Y., Hong S.-C., et al. ERK and p38 MAPK signaling pathways negatively regulate CIITA gene expression in dendritic cells and macrophages. J Immunol 177 (2006) 70-76
22. Deb D.K., Sassano A., Lekmine F., Majchrzak B., Verma A., Kambhampati S., et al. Activation of protein kinase Cδ by IFN-γ. J Immunol 171 (2003) 267-273
23. Nikodemova M., Watters J.J., Jackson S.J., Yang S.K., and Duncan I.D. Minocycline down-regulates MHC II expression in microglia and macropgages through inhibition of IRF-1 and protein kinase C (PKC)α/βII. J Biol Chem 282 (2007) 15208-15216
24. Fiehn C., Prummer O., Gallati H., Heilig B., and Hunstein W. Treatment of systemic mastocytosis with interferon-γ: failure after appearance of anti-IFN-γ antibodies. Eur J Clin Invest 25 (1995) 615-618
25. Nafziger J., Arock M., Guillosson J.J., and Wietzerbin J. Specific high-affinity receptors for interferon-γ on mouse bone marrow-derived mast cells: inhibitory effect of interferon-γ on mast cell precursors. Eur J Immunol 20 (1990) 113-117
26. Kirshenbaum A.S., Worobec A.S., Davis T.A., Goff J.P., Semere T., and Metcalfe D.D. Inhibition of human mast cell growth and differentiation by interferon-γ-1b. Exp Hematol 26 (1998) 245-251
27. Bissonnette E.Y., Chin B., and Befus A.D. Interferons differentially regulate histamine and TNF-α in rat intestinal mucosal mast cells. Immunology 86 (1995) 12-17
28. Fairweather D., Frisancho-Kiss S., Yusung S.A., Barrett M.A., Davis S.E., Gatewood S.J., et al. Interferon-γ protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-β, interleukin-1, and interleukin-4 in the heart. Am J Pathol 165 (2004) 1883-1894
29. Kulka M., Dery R., Nahirney D., Duszyk M., and Befus A.D. Differential regulation of cystic fibrosis transmembrane conductance regulator by interferon-γ in mast cells and epithelial cells. J Pharmacol Exp Ther 315 (2005) 563-570
30. Tachimoto H., Ebisawa M., Hasegawa T., Kashiwabara T., Ra C., Bochner B.S., et al. Reciprocal regulation of cultured human mast cell cytokine production by IL-4 and IFNγ. J Allergy Clin Immunol 106 (2000) 141-149
31. Okayama Y., Hagaman D.D., and Metcalfe D.D. A comparison of mediators released or generated by IFNγ-treated human mast cells following aggregation of FcγRI or FcεRI. J Immunol 166 (2001) 4705-4712
32. Mann-Chandler M.N., Kashyap M., Wright H.V., Norozian F., Barnstein B.O., Gingras S., et al. IFN-γ induces apoptosis in developing mast cells. J Immunol 175 (2005) 3000-3005
33. Abrink M., Grujic M., and Pejler G. Serglycin is essential for maturation of mast cell secretory granule. J Bioll Chem 279 (2004) 40897-40905
34. Picado C., Bioque G., Roca-Ferrer J., Pujols L., Mullol J., et al. Nuclear factor-κB activity is down-regulated in nasal polyps from aspirin-sensitive asthmatics. Allergy 58 (2003) 122-126
35. Di Girolamo N.D., Indoh I., Jackson N., Wakefield D., McNeil H.P., Yan W., et al. Human mast cell-derived gelatinase B (matrix metalloproteinase-9) is regulated by inflammatory cytokines: role in cell migration. J Immunol 177 (2006) 2638-2650
36. Kim J.Y., and Ro J.Y. Signal pathway of cytokines produced by reactive oxygen species generated from phorbol myristate acetate-stimulated HMC-1 cells. Scan J Immunol 62 (2005) 25-35
37. Lin X., Takemori H., Katoh Y., Doi J., Horike N., Makino A., et al. Salt-inducible kinase is involved in the ACTH/cAMP-dependent protein kinase signaling in Y1 mouse adrenocortical tumor cells. Mol Endocrinol 15 (2001) 1264-1276
38. Sarri E., Pardo R., Fensome-Green A., and Cockcroft S. Endogenous phospholipase D2 localizes to the plasma membrane of RBL-2H3 mast cells and can be distinguished from ADP ribosylation factor-stimulated phospholipase D1 activity by its specific sensitivity to oleic acid. Biochem J 369 Pt 2 (2003) 319-329
39. Desmet C., Gosset P., Pajak B., Cataldo D., Bentires-Alj M., Lekeux P., et al. Selective blockade of NF-κB activity in airway immune cells inhibits the effector phase of experimental asthma. J Immunol 173 (2004) 5766-5775
40. Masuda A., Hashmoto K., Yokoi T., Doi T., Kodama T., Kume H., et al. Essentail role of GATA transcriptional factors in the activation of mast cells. J Immunol 178 (2007) 360-368
41. Ramana C.V., Gil M.P., Schreiber R.D., and Stark G.R. Stat1-dependent and-independent pathways in IFNγ-dependent signaling. Trands Immunol 23 (2002) 96-101
42. Renauld J.-C. New insight into the role of cytokines in asthma. J Clin Pathol 54 (2001) 577-589
43. Leung D.Y.M., Boguniewicz M., Howell M.D., Nomura I., and Hamid Q.A. New insight into atopic dermatitis. J Clin Invest 113 (2004) 651-657
44. Xuan Y.-T., Guo Y., Zhu Y., Wang O.-L., Rokosh G., Messing R.O., et al. Role of the protein kinase C-ε-Raf-1-MEK-1/2-p44/42 MAPK signaling cascade in the activation of signal transducers and activators of transcription 1 and 3 induction of cyclooxygenase-2 after ischemic preconditioning. Circulation 112 (2005) 1971-1978
45. Platanias L.C. Mechanisms of type-I- and type-II-interferons-mediated signaling. Nat Rev Immunol 5 (2005) 375-386
46. Uddin S., Sassano A., Deb D.K., Verma A., Majchrzak B., Rahman A., et al. Protein kinase C-δ (PKC-δ) is activated by type I interferons and mediates phosphorylation of Stat1 on serine 727. J Biol Chem 277 (2002) 14408-14416
47. Gough D.J., Sabapathy K., Y-N Ko.E., Arthur H.A., Schreiber R.D., Trapani J.A., et al. A novel c-Jun-dependent signal transduction pathway necessary for the transcriptional activation of interferon γ response genes. J Biol Chem 282 (2007) 938-946
48. Ramsauer K., Sadzak I., Porras A., Pilz A., Nebreda A.R., Decker T., et al. P38 MAPK enhances STAT1-dependent transcription independently of Ser-727 phosphorylation. Proc Natl Acad Sci USA 99 (2002) 12859-12864
49. Sica A., Dorman L., Viggiano V., Cippitelli M., Ghosh P., Rice N., et al. Interaction of NF-κB and NFAT with the interferon-gamma promoter. J Biol Chem 272 (1997) 30412-30420
50. Deb A., Haque J., Mogensen T., Silverman R.H., and Williams B.R.G. RNA-dependent protein kinase PKB is required for activation of NF-κB by IFNγ in a STAT1-independent pathway. J Immunol 166 (2001) 6170-6180
51. Horvai A.E., Xu L., Korzus E., Brard G., Kalafus D., Mullen T.-M., et al. Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300. Proc Natl Acad Sci USA 94 (1997) 1074-1079
52. Masuda A., Yoshikai Y., Kume H., and Matsuguchi T. The interaction between GATA proteins and activator protein-1 promotes the transcription of IL-13 in mast cells. J Immunol 173 (2004) 5564-5573
53. Chen G-Y, Sakuma K, Kannagi R. Significance of NF-κB/GATA axis in TNFα-induced expression of 6-sulfated cell-recognition glycans in human-lymphocytes. J Biol Chem. doi: 10.1074/jbc.M804271200.